Laboratoris d'Immunologia i Diagnòstic Molecular Generalitat de Catalunya - Departament de Salut Banc de Sang i Teixits
Home
Teaching
Back
Publications 2010
  Ballana E, Senserrich J, Pauls E, Faner R, Mercader JM, Uyttebroeck F, Palou E, Mena MP, Grau E, Clotet B, Ruiz L, Telenti A, Ciuffi A, Esté JA. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression CLIN INFECT DIS 50(7); 1022-1032, 2010. QUARTIL 1, DECIL 1, FACTOR D'IMPACTE 8,26.
  Brckalo T, Calzetti F, Pérez-Cabezas B, Borràs FE, Cassatella MA, López-Botet M. Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cells EUR J IMMUNOL 40(3); 722-32, 2010. QUARTIL 1, DECIL 2, FACTOR D'IMPACTE: 4,86
  Trallero-Araguás E, Labrador-Horrillo M, Selva-O'Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarrés M. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy MEDICINE 89(1); 47-52, 2010. QUARTIL 1, DECIL 2, FACTOR D'IMPACTE 4,33.
  Soldevila B, Alonso N, Martínez-Arconada MJ, Morillas RM, Planas R, Sanmartí AM, Martínez-Cáceres EM. A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4CD25CD127FoxP3 T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment. doi:10.1111/j.1365-2893.2010.01317.x. J VIRAL HEPATITIS May; 10, 2010. QUARTIL 1, DECIL 3, FACTOR D'IMPACTE 3,32.
  Colobran R, Pedrosa E, Carretero-Iglesia L, Juan M. Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease CLIN EXP IMMUNOL; Oct; 162 (1): 41-52, 2010. QUARTIL 2, DECIL 5, FACTOR D'IMPACTE 2,85.
  Planas R, Pujol-Borrell R, Vives-Pi M. Global gene expression changes in type 1 diabetes: Insights into autoimmune response in the target organ and in the periphery IMMUNOL LETT ; , 2010. QUARTIL 2, DECIL 5, FACTOR D'IMPACTE 2,85.
  Ortiz-Santamaria V, Olive A, Martinez-Caceres E, Coll M, Codina X, Suris X. Neonatal lupus erythematosus: a possible role for anti-Sm antibodies LUPUS 19(5); 659-661, 2010. QUARTIL 3, DECIL 6, FACTOR D'IMPACTE 2,24.
  Alonso N, Granada ML, Soldevila B, Salinas I, Joaquin C, Reverter JL, Juncà J, Martínez Cáceres EM, Sanmartí A. Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in pattients with type 1 diabetes mellitus: a 5-year prospective study J ENDOCRINOL INVEST ; , 2010. QUARTIL 4, DECIL 8, FACTOR D'IMPACTE 1,88
  Lucas A, Julián MT, Cantón A, Castell C, Casamitjana R, Martínez-Cáceres EM, Granada ML. Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population ENDOCRINE 38(3); 391-396, 2010. QUARTIL 4, DECIL 8, FACTOR D'IMPACTE 1,84.
  Balibrea del Castillo JM, Arias-Díaz J, García Martín MC, Vives-Pi M, García Pérez JC, Cantero Cid R, Vara Ameigeiras E, Balibrea Cantero JL. Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines CIRUGIA ESPAÑOLA 87(6); 372-377, 2010
  Grau-López L, Sierra S, Martínez-Cáceres E, Ramo-Tello C. Analysis of the pain in multiple sclerosis patients NEUROLOGIA Dec 16; , 2010
  Herrero MJ. ABC de los «Toll-like receptors»: relación con el desarrollo y progresión de enfermedades autoinmunes SEMINARIOS DE LA FUNDACION ESPAÑOLA DE REUMATOLOGIA 11(4); 135-143, 2010
  Izquierdo-Useros N, Naranjo-Gómez M, Erkizia I, Puertas MC, Borrás FE, Blanco J, Martinez-Picado J. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLOS PATHOG 6(3); e1000740, 2010
  vanZyl B, Planas R, Ye Y, Foulis A, de Krijger R, Vives-Pi M, Gillespie K. Why are levels of maternal microchimerism higher in type 1 diabetes pancreas? CHIMERISM 1 (2); 1-6, 2010
  Vives-Pi M, Sabater L. Stiff person syndrome and cerebellar ataxia associated with glutamic acid decarboxylase antibodies and type 1 diabetes: What is the link between neurological diseases and autoimmunity to the beta cell? INMUNOLOGIA 29(4); 119-124, 2010

Top Top
© 2006 Laboratori d'Immunologia i Diagnòstic Molecular. All rights reserved - Legal Disclaimer